Skip to Main Content

Paper Details

Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.
PLoS One
34
2019
AML, AML cell lines, Acute, Acute myeloid leukemia, C(cys), HLA, HLA Class I and II immunopeptidome, HLA Class I ligands, HLA haplotypes, HLA ligands, HLA-A*02:01, HLA-A*03:01, MV4-, NPM1, OCI-AML3, cancer, endogenous, mutated nucleophosmin, nucleophosmin, patient, patients
Author NameAffiliation
Bruno C MedeirosStanford University
Mark M DavisStanford University
Mark M DavisHoward Hughes Medical Institute, Stanford University
Joshua E EliasStanford University
  • 1 - 4

Datasets

Release 1.2